FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts

FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts

Source: 
Xconomy
snippet: 

The FDA has placed a clinical hold on a LogicBio Therapeutics application to begin human testing of its experimental gene-editing therapy for a rare, inherited liver disorder.